InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-16.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Kenney Christopher John. Officer active across 2 companies, notably Xenon Pharmaceuticals Inc.. In total, 4 reports have been recorded. Split: 1 buy · 1 sell. Total volume traded: €40k. History available since 21 January 2022. The latest transaction was disclosed on 24 March 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kenney Christopher John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
3,750 sharesCommon SharesSEC:0001193125-26-106727:0
7,500 sharesCommon SharesSEC:0001193125-26-102669:0
700 shares@ US$35.01100.0% of flowCommon SharesSEC:0001209191-23-021136:0
700 shares@ US$28.810.0003% mcap50.0% of flowCommon SharesSEC:0001209191-22-004460:0
Canonical exit: 21 Apr 2022 (T+90)
4 of 4 declarations
